Implementing tuberculosis control programmes in Kaduna State, Nigeria.
This paper discusses the impact of pre-payment versus free drug therapy on case-finding and treatment of tuberculosis patients. While the Kaduna State tuberculosis pilot project introduced fees mainly as a cost-recovery measure, evaluation of several cohorts revealed that while it led to a reduction in the proportion of diagnosed smear-positive patients that could afford treatment, it markedly enhanced compliance in those willing to pay. Ways to balance this trade-off are suggested.